Mikael Henriksson

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Patents and Intellectual Property – Strategic Aspects

By Joanna Applequist, Mikael Henriksson | Posted on February 6, 2023

As part of Redeye’s ProView series, Jessica Martinsson, COO of Sprint Bioscience joins European patent attorneys Joanna Applequist and Mikael Henriksson, as well as Redeye’s equity analyst Ethel Luvall to discuss patents, intellectual property and dive deep into the legal and strategic aspects of different businesses.                  ...

Tags: Intellectual Property, patents, strategy

Determining the Value of Patents during an Investment or Sale

By Joanna Applequist, Mikael Henriksson | Posted on October 1, 2021

Joanna Applequist and Mikael Henriksson speak on IP matters that companies should consider preparing for during an investment or sale during this seminar hosted by Stockholm Science City. Joanna and Mikael were joined by David Bejker from Affibody AB and Jonas Jendi from Industrifonden. This webinar is in Swedish. 

Tags: investment, patents, sale, strategy

New dosage regimen may be patented, but no more Swiss-type claims

By Mikael Henriksson | Posted on February 23, 2010

The Enlarged Board of Appeal of the EPO clarifies, in decision G 2/08 of 19 February 2010, that it is possible to obtain a patent for a medicament known to treat a specific illness for use in a different method for treatment of the same illness. However, such inventions may not be claimed in the...

Tags: Enlarged Board of Appeal. Swiss-type claims, European patent application

New EPO practice on the patentability of surgical methods

By Mikael Henriksson | Posted on February 17, 2010

The Enlarged Board of Appeal of the European Patent Office has in its latest decision G 1/07 of 15 February 2010 provided guidelines on the exception to patentability on methods for treatment of the body by surgery. The purpose of this exclusion is to free the medical profession from constraints by patents. The context of...

Tags: Enlarged Board of Appeal, European patent, patentability

Recent contributors

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law

Ai-Leen Lim

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Mikkel Roed Trier

Mikkel Roed Trier

Partner, European Patent Attorney, UPC Representative, Business Area Manager